Skip to main content

Kazia Therapeutics LTD (KZIA)

Sector
Healthcare
Industry
Biotechnology
Last price
$5.31
As of

Kresmion compiles this page from KZIA's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

KAZIA THERAPEUTICS LTD (KZIA): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-09-22.

As of . Source: SEC EDGAR filings for KZIA. Method and limitations.

COMPANY DOSSIER

See the full KZIA dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for KZIA on one page. Preview it with sample data, then open it live with a free account.

Preview the KZIA dossier

Active events for KZIA

FREE, NO ACCOUNT

Every event on KZIA, as it fires

You are seeing 5 of 10 events recorded on KZIA since 2026-05-30.

The five above landed across 3 days. The other 5 were recorded on 1 other days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.

Recent SEC filings, KZIA

More data on KZIA

KZIA against its peers

KZIA's net margin of -49290.5% ranks in the 12th percentile of 11 Biotechnology sub-industry peers, fiscal periods ending between 2024-12-31 and 2026-04-30.

MetricKZIAPeer medianPercentilen
Revenue FY42000 AUDn/an/a0
Revenue YoY-98.2%n/an/a1
Operating marginn/a-352.2%n/a11
Net margin-49290.5%-267.1%1311
Return on equityn/a-53.7%n/a20
1 year-27.6%-48.2%7521

Peers (24): OKYO, TENX, NRXS, TLSA, ATRA, TNYA, SMNR, NMRA, CHRS, CRBP, GOSS, MNOV, PLYX, GNLX, BDTX, VTVT, RLYB, NTRB, ACRV, NKTX, CSBR, CING, AVXL, COYA. Left out: CNXU (no annual filing). Fiscal periods ending between 2024-12-31 and 2026-04-30. Every figure is one full fiscal year read from one annual filing (KZIA: 20-F), reported in AUD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Cite this data

Kresmion counts the managers it follows that reported a non-option position in KZIA on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on KZIA in the last 180 days.

Upstream: SEC EDGAR filings for KZIA

Kresmion, "KAZIA THERAPEUTICS LTD (KZIA) institutional holdings and SEC filings", data as of 2026-09-22, https://kresmion.com/research/KZIA. Upstream data: SEC EDGAR filings for KZIA.

Link to this data (HTML):

<a href="https://kresmion.com/research/KZIA">KAZIA THERAPEUTICS LTD (KZIA) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow KZIA on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to KZIA for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the KZIA dossier
Share

The KZIA intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.